PT2352472T - Equivalentes de pele secos e irradiados prontos a utilizar - Google Patents

Equivalentes de pele secos e irradiados prontos a utilizar

Info

Publication number
PT2352472T
PT2352472T PT98253255T PT09825325T PT2352472T PT 2352472 T PT2352472 T PT 2352472T PT 98253255 T PT98253255 T PT 98253255T PT 09825325 T PT09825325 T PT 09825325T PT 2352472 T PT2352472 T PT 2352472T
Authority
PT
Portugal
Prior art keywords
dried
skin equivalents
ready use
irradiated skin
irradiated
Prior art date
Application number
PT98253255T
Other languages
English (en)
Portuguese (pt)
Inventor
Lynn Allen-Hoffmann B
R Comer Allen
Steiglitz Barry
Original Assignee
Stratatech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratatech Corp filed Critical Stratatech Corp
Publication of PT2352472T publication Critical patent/PT2352472T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A61F2/105—Skin implants, e.g. artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
PT98253255T 2008-11-04 2009-11-04 Equivalentes de pele secos e irradiados prontos a utilizar PT2352472T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11115308P 2008-11-04 2008-11-04

Publications (1)

Publication Number Publication Date
PT2352472T true PT2352472T (pt) 2017-04-11

Family

ID=42153209

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98253255T PT2352472T (pt) 2008-11-04 2009-11-04 Equivalentes de pele secos e irradiados prontos a utilizar

Country Status (10)

Country Link
US (5) US8580314B2 (enExample)
EP (1) EP2352472B1 (enExample)
JP (2) JP5632383B2 (enExample)
CN (1) CN102271634B (enExample)
AU (1) AU2009313656B2 (enExample)
CA (1) CA2742595C (enExample)
DK (1) DK2352472T3 (enExample)
ES (1) ES2621324T3 (enExample)
PT (1) PT2352472T (enExample)
WO (1) WO2010053948A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090145087A1 (en) 2007-11-14 2009-06-11 Stratatech Corporation Cold storage of organotypically cultured skin equivalents for clinical applications
JP5632383B2 (ja) 2008-11-04 2014-11-26 ストラタテック コーポレーション 即時使用のための乾燥され、放射線照射された皮膚同等物
US20100330046A1 (en) * 2009-05-21 2010-12-30 Stratatech Corporation Human skin substitutes expressing il-12
EP3470018B1 (en) * 2013-03-13 2021-07-28 Stratatech Corporation Cryopreservation of viable human skin substitutes
KR101701396B1 (ko) 2014-10-28 2017-02-01 주식회사 엑티저 오디오 신호 처리 장치 및 방법
US20220287298A1 (en) * 2017-01-27 2022-09-15 Stratatech Corporation Tissue container systems
JP2022549688A (ja) * 2019-09-27 2022-11-28 ストラタテック コーポレーション 急性創傷を治療し、転帰を改善するための方法
IL297372A (en) * 2020-05-13 2022-12-01 Stratatech Corp Sustainable bioengineered skin constructs

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
IL95429A (en) * 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
CA2080693C (en) * 1990-04-24 2001-11-27 Mark Eisenberg Composite living skin equivalents
US6585969B1 (en) * 1991-11-20 2003-07-01 N. V. Innogenetics S.A. Non-viable keratinocyte cell composition or lysate for promoting wound healing
EP0970701B1 (en) * 1991-11-20 2005-10-26 Innogenetics N.V. Pellets derived from keratinocytes for use as wound healing substances
AU4106796A (en) * 1994-11-09 1996-06-06 Federico Castro Munozledo Wound repair dressings and methods for their preservation
US5693332C1 (en) * 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
JP3377354B2 (ja) * 1995-12-25 2003-02-17 株式会社メニコン 人工皮膚
US5968546A (en) * 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells
US5989837A (en) * 1998-07-13 1999-11-23 Wisconsin Alumni Research Foundation Immortalized human keratinocyte cell line
EP1198557B1 (en) * 1999-07-20 2006-05-03 DFB Pharmaceuticals, Inc. Improved keratinocyte culture and uses thereof
US6866686B2 (en) 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6974697B2 (en) * 2001-03-02 2005-12-13 Stratech Corporation Skin substitutes with improved barrier function
WO2002070729A2 (en) * 2001-03-02 2002-09-12 Stratatech Corporation Improved skin substitutes and uses thereof
DE60332256D1 (de) * 2002-04-30 2010-06-02 Stratatech Corp Exogene angiogene wachstumsfaktoren exprimierende keratinozyten
WO2004013606A2 (en) 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
US7993922B2 (en) * 2002-10-18 2011-08-09 Reliance Life Sciences Pvt. Ltd. Three-dimensional tissue equivalent using macromass culture
JP2006526413A (ja) * 2003-05-30 2006-11-24 ストラタテック コーポレーション 臓器の室温保存法
EP3100611B1 (en) * 2003-08-01 2018-09-12 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
CA2758178C (en) 2003-08-01 2016-10-11 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
AU2005215211B2 (en) * 2004-02-13 2011-11-03 Smith & Nephew Orthopaedics Ag Wound healing profile
WO2006055931A2 (en) 2004-11-18 2006-05-26 Stratatech Corporation Vectors for stable gene expression
CA2600177C (en) 2005-03-01 2011-06-14 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
WO2006101834A1 (en) 2005-03-17 2006-09-28 Stratatech Corporation Skin substitutes with improved purity
CN100400655C (zh) 2005-12-02 2008-07-09 王平安 组织工程化细胞外基质的制备方法
US20090145087A1 (en) * 2007-11-14 2009-06-11 Stratatech Corporation Cold storage of organotypically cultured skin equivalents for clinical applications
JP5632383B2 (ja) 2008-11-04 2014-11-26 ストラタテック コーポレーション 即時使用のための乾燥され、放射線照射された皮膚同等物
US20100330046A1 (en) * 2009-05-21 2010-12-30 Stratatech Corporation Human skin substitutes expressing il-12

Also Published As

Publication number Publication date
US20170087276A1 (en) 2017-03-30
US9867904B2 (en) 2018-01-16
JP5632383B2 (ja) 2014-11-26
US20150196686A1 (en) 2015-07-16
JP2014221417A (ja) 2014-11-27
JP2012508064A (ja) 2012-04-05
CA2742595C (en) 2014-04-01
CA2742595A1 (en) 2010-05-14
CN102271634A (zh) 2011-12-07
AU2009313656B2 (en) 2014-02-20
CN102271634B (zh) 2015-01-14
ES2621324T3 (es) 2017-07-03
US20100119615A1 (en) 2010-05-13
AU2009313656A1 (en) 2010-05-14
EP2352472A4 (en) 2014-03-05
DK2352472T3 (en) 2017-04-10
EP2352472B1 (en) 2017-01-04
US8580314B2 (en) 2013-11-12
US8685463B2 (en) 2014-04-01
US20140067064A1 (en) 2014-03-06
WO2010053948A1 (en) 2010-05-14
US9526811B2 (en) 2016-12-27
US20140288165A1 (en) 2014-09-25
US8992997B2 (en) 2015-03-31
EP2352472A1 (en) 2011-08-10

Similar Documents

Publication Publication Date Title
IL290501A (en) Systems and methods for extracorporeal lung preservation
IL268776B (en) il-1a antibodies and methods of use
GB2463797B (en) Skin treating device
IL230911A0 (en) A system for the treatment of heart tissue and its use
ZA201107917B (en) Applicator device for cosmetic and/or medical use
IL208458A0 (en) Compositions and methods for skin care
IL211816A0 (en) Airflow applicators and related treatment methods
SI2282675T1 (sl) Sistem za kozmetični tretma in slikanje
GB0800144D0 (en) Electrocardiographic device and method
GB0803018D0 (en) Therapeutic compounds and their use
GB0804685D0 (en) Therapeutic compounds and their use
GB0807609D0 (en) Therapeutic compounds and their use
GB0817208D0 (en) Therapeutic apsap compounds and their use
IL208771A0 (en) Iminopyridine derivatives and use thereof
EP2284515A4 (en) APPARATUS FOR TREATING A FABRIC PIECE
GB0816650D0 (en) Therapeutic bone grwth and regeneration
EP2499931A4 (en) APPLICATOR AND DEVICE FOR PARTIAL HAIR COLORING
GB0812913D0 (en) Therapeutic compounds and their use
ZA201105441B (en) Ethanamine compounds and their use for treating depression
HUP0800340D0 (en) Device for skin care with light-therapy
GB0802128D0 (en) Therapeutic compounds and their use
GB0813352D0 (en) Cancer treatment and test
GB0903161D0 (en) Disposable stethescope cover and applicator
GB0821539D0 (en) Therapeutic compounds and their use
GB0815134D0 (en) Therapeutic compounds and their use